Cartesian Therapeutics (RNAC) EBT (2015 - 2026)
Cartesian Therapeutics' (RNAC) quarterly EBT came in at -$26.6 million in Q1 2026, down 31.95% year-on-year from -$39.2 million in Q1 2025, and up 64.59% on a QoQ basis from -$75.2 million in Q4 2025.
Cartesian Therapeutics (RNAC) EBT (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of EBT data on file, last reported at -$26.6 million in Q1 2026.
- On a quarterly basis, EBT fell 31.95% year-over-year to -$26.6 million in Q1 2026; TTM through Mar 2026 was -$163.6 million, a 74.36% decrease from a year earlier, with the FY2025 full-year figure at -$139.5 million, down 80.84% from the prior year.
- EBT for Q1 2026 stood at -$26.6 million, up from -$75.2 million in the prior quarter.
- Over the last five years, EBT for RNAC reached as high as $13.4 million in Q2 2022 and fell as low as -$196.7 million in Q4 2023.
- Historically, EBT has averaged -$29.7 million across 5 years, with a median of -$20.2 million in 2025.
- Across the five-year window, EBT surged 5275.19% in 2022 and sank 3608.62% in 2023, its largest moves.
- Year by year, EBT stood at $5.6 million in 2022, then sank by 3608.62% to -$196.7 million in 2023, then jumped by 87.14% to -$25.3 million in 2024, then tumbled by 197.55% to -$75.2 million in 2025, then soared by 64.59% to -$26.6 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$26.6 million in Q1 2026, -$75.2 million in Q4 2025, and -$24.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Cartesian Therapeutics | 210.28 Mn | 210.28 Mn | - | -26.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.64 Mn |
| Dec 31, 2025 | -75.24 Mn |
| Sep 30, 2025 | -24.61 Mn |
| Jun 30, 2025 | -37.09 Mn |
| Mar 31, 2025 | -20.19 Mn |
| Dec 31, 2024 | -25.29 Mn |
| Sep 30, 2024 | -30.21 Mn |
| Jun 30, 2024 | -18.13 Mn |
| Mar 31, 2024 | -24.88 Mn |
| Dec 31, 2023 | -196.66 Mn |
| Sep 30, 2023 | -9.00 Mn |
| Jun 30, 2023 | -18.00 Mn |
| Mar 31, 2023 | -19.18 Mn |
| Dec 31, 2022 | 5.61 Mn |
| Sep 30, 2022 | -8.21 Mn |
| Jun 30, 2022 | 13.35 Mn |
| Mar 31, 2022 | 10.08 Mn |
| Dec 31, 2021 | 12.38 Mn |
| Sep 30, 2021 | -2.07 Mn |
| Jun 30, 2021 | -258,000.00 |